Placebo-Controlled, Double-Blind, Prospective, Randomized Study on the Effect of Octreotide LAR in the Control of Tumor Growth in Patients with Metastatic Neuroendocrine Midgut Tumors (PROMID): Results of Long-Term Survival (Q40145023)
Jump to navigation
Jump to search
scientific article published on 6 January 2016
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Placebo-Controlled, Double-Blind, Prospective, Randomized Study on the Effect of Octreotide LAR in the Control of Tumor Growth in Patients with Metastatic Neuroendocrine Midgut Tumors (PROMID): Results of Long-Term Survival |
scientific article published on 6 January 2016 |
Statements
1 reference
Placebo-Controlled, Double-Blind, Prospective, Randomized Study on the Effect of Octreotide LAR in the Control of Tumor Growth in Patients with Metastatic Neuroendocrine Midgut Tumors (PROMID): Results of Long-Term Survival (English)
1 reference
Carmen Schade-Brittinger
1 reference
Anja Rinke
1 reference
Michael Wittenberg
1 reference
Behnaz Aminossadati
1 reference
Erdmuthe Ronicke
1 reference
Hans-Helge Müller
1 reference
Rudolf Arnold
1 reference
PROMID Study Group
1 reference
6 January 2016
1 reference
1 reference
Identifiers
1 reference